Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 08 2019
05 08 2019
Historique:
received:
01
04
2019
accepted:
12
07
2019
entrez:
7
8
2019
pubmed:
7
8
2019
medline:
24
10
2020
Statut:
epublish
Résumé
Although obesity represents a risk factor for the development of type 2 diabetes mellitus (T2DM), the link between these pathological conditions is not so clear. The manner in which the different elements of adipose tissue (AT) interplay in order to grow has been suggested to have a role in the genesis of metabolic complications, but this has not yet been fully addressed in humans. Through IHC, transmission electron microscopy, cytometry, and in vitro cultures, we described the morphological and functional changes of subcutaneous and visceral AT (SAT and VAT) in normoglycemic, prediabetic and T2DM patients with obesity compared to lean subjects. In both SAT and VAT we measured a hypertrophic and hyperplastic expansion, causing similar vascular rarefaction in obese patients with different degrees of metabolic complications. Capillaries display dysfunctional basement membrane thickening only in T2DM patients evidencing VAT as a new target of T2DM microangiopathy. The largest increase in adipocyte size and decrease in adipose stem cell number and adipogenic potential occur both in T2DM and in prediabetes. We showed that SAT and VAT remodeling with stemness deficit is associated with early glucose metabolism impairment suggesting the benefit of an AT-target therapy controlling hypertrophy and hyperplasia already in prediabetic obese patients.
Identifiants
pubmed: 31383894
doi: 10.1038/s41598-019-47719-y
pii: 10.1038/s41598-019-47719-y
pmc: PMC6683173
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11333Références
Diabetes. 2007 Apr;56(4):901-11
pubmed: 17395738
BMC Physiol. 2012 Apr 02;12:4
pubmed: 22471305
Diabetes. 2010 Nov;59(11):2755-63
pubmed: 20713685
Cell Metab. 2014 Jan 7;19(1):8-20
pubmed: 24239569
Obesity (Silver Spring). 2006 Sep;14(9):1543-52
pubmed: 17030965
Cytometry A. 2013 Jan;83(1):134-40
pubmed: 23184564
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S35-42
pubmed: 19179216
Chest. 2014 Nov;146(5):1387-1394
pubmed: 25367475
J Cardiovasc Transl Res. 2011 Apr;4(2):200-10
pubmed: 21327755
Diabetes. 2009 Mar;58(3):718-25
pubmed: 19074987
Nature. 2006 Dec 14;444(7121):881-7
pubmed: 17167477
J Clin Invest. 2011 Jun;121(6):2094-101
pubmed: 21633177
J Hypertens. 2013 Jul;31(7):1281-357
pubmed: 23817082
Obesity (Silver Spring). 2016 Mar;24(3):597-605
pubmed: 26916240
Diabetes. 2006 May;55(5):1353-60
pubmed: 16644692
Diabetologia. 2000 Dec;43(12):1498-506
pubmed: 11151758
Nat Genet. 2000 Sep;26(1):13
pubmed: 10973236
Cell Metab. 2013 Jan 8;17(1):61-72
pubmed: 23312284
Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):539-46
pubmed: 23037900
Mol Cell Biol. 2009 Aug;29(16):4467-83
pubmed: 19546236
Cell Stem Cell. 2017 May 4;20(5):587-589
pubmed: 28475883
Cell Metab. 2013 Oct 1;18(4):470-7
pubmed: 23954640
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H654-66
pubmed: 27371680
Diabetologia. 2016 Jun;59(6):1075-88
pubmed: 27039901
Br J Nutr. 2008 Aug;100(2):227-35
pubmed: 18397542
Circulation. 2008 Aug 26;118(9):968-76
pubmed: 18725503
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Biochim Biophys Acta. 2014 Mar;1842(3):463-72
pubmed: 23770388
Sci Rep. 2017 Dec 14;7(1):17569
pubmed: 29242563
Mech Ageing Dev. 1982 Aug;19(4):315-24
pubmed: 7132438
Diabetes. 2013 May;62(5):1417-25
pubmed: 23274888
J Clin Invest. 2017 Jan 3;127(1):74-82
pubmed: 28045400
Mol Aspects Med. 2013 Feb;34(1):59-70
pubmed: 23068072
Lancet. 2014 Mar 22;383(9922):1068-83
pubmed: 24315620
Circulation. 2011 Jan 18;123(2):186-94
pubmed: 21200001